Jie Tao Selected Research

makatoxin I (BMK I)

1/2018	Up-Regulation of Akt and Nav1.8 in BmK I-Induced Pain.
1/2016	Parkinson's disease-like forelimb akinesia induced by BmK I, a sodium channel modulator.
6/2015	Lipid bilayer modification alters the gating properties and pharmacological sensitivity of voltage-gated sodium channel.
1/2015	Allosteric interactions between receptor site 3 and 4 of voltage-gated sodium channels: a novel perspective for the underlying mechanism of scorpion sting-induced pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Tao Research Topics

Disease

9	Infections 01/2022 - 07/2010
9	Neoplasms (Cancer) 01/2022 - 01/2014
8	Epilepsy (Aura) 01/2021 - 01/2018
6	Inflammation (Inflammations) 06/2022 - 01/2018
6	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 03/2010 - 08/2006
4	Hypoxia (Hypoxemia) 02/2022 - 04/2010
3	Diarrhea 01/2022 - 02/2018
3	Orthomyxoviridae Infections 01/2022 - 01/2018
3	Parkinson Disease (Parkinson's Disease) 06/2019 - 01/2016
3	Neuroblastoma 10/2018 - 12/2009
3	Atherosclerosis 10/2018 - 10/2011
3	Pain (Aches) 10/2018 - 01/2015
3	Hypertension (High Blood Pressure) 10/2017 - 06/2014
2	Sepsis (Septicemia) 06/2022 - 01/2019
2	Hemorrhage 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2016
2	Pathologic Constriction (Stenosis) 01/2022 - 08/2008
2	Brain Diseases (Brain Disorder) 01/2022 - 01/2020
2	Ileus 01/2022 - 01/2022
2	Neuroinflammatory Diseases 01/2021 - 01/2019
2	Drug Resistant Epilepsy 12/2020 - 01/2020
2	Brain Ischemia (Cerebral Ischemia) 11/2020 - 06/2020
2	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2014
2	Bone Diseases (Bone Disease) 01/2020 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 09/2017
2	Hyperalgesia 10/2018 - 01/2015
2	Human Influenza (Influenza) 01/2018 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2017 - 01/2014
2	Glioma (Gliomas) 01/2017 - 03/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2014 - 05/2013
2	Starvation 05/2013 - 06/2010
1	Vascular Calcification 03/2022
1	Adenocarcinoma of Lung 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Urinary Retention 01/2022
1	Anastomotic Leak 01/2022
1	Flatulence 01/2022
1	Ureteral Obstruction 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Coinfection 01/2022
1	Wound Infection (Wound Infections) 01/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2017
5	Inosine Triphosphate (ITP)IBA 03/2010 - 08/2006
4	Messenger RNA (mRNA)IBA 01/2022 - 08/2008
4	Voltage-Gated Sodium ChannelsIBA 01/2020 - 01/2015
4	makatoxin I (BMK I)IBA 01/2018 - 01/2015
3	CalciumIBA 03/2022 - 01/2018
3	MicroRNAs (MicroRNA)IBA 02/2022 - 09/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2020
3	CholesterolIBA 08/2021 - 07/2010
3	C-Reactive ProteinIBA 08/2021 - 10/2014
3	LDL CholesterolIBA 08/2021 - 10/2014
3	Anticonvulsants (Antiepileptic Drugs)IBA 12/2020 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 07/2014
3	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2020 - 03/2011
3	AntibodiesIBA 01/2015 - 08/2006
2	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 01/2017
2	Tryptophan (L-Tryptophan)FDA Link 06/2022 - 01/2019
2	AlbuminsIBA 06/2022 - 01/2021
2	EnzymesIBA 02/2022 - 08/2015
2	Potassium Channels (Potassium Channel)IBA 01/2022 - 01/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2019
2	IronIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 08/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2021 - 01/2021
2	HDL CholesterolIBA 08/2021 - 10/2014
2	Blood Glucose (Blood Sugar)IBA 08/2021 - 10/2014
2	oxidized low density lipoproteinIBA 07/2021 - 01/2020
2	Neuroprotective AgentsIBA 06/2020 - 06/2019
2	PotassiumIBA 01/2019 - 01/2018
2	Antiviral Agents (Antivirals)IBA 01/2018 - 04/2017
2	Sodium Channels (Sodium Channel)IBA 01/2016 - 06/2015
2	VenomsIBA 06/2015 - 01/2015
2	BmK AS polypeptideIBA 06/2015 - 12/2009
2	VaccinesIBA 11/2014 - 02/2013
2	Caspase 3 (Caspase-3)IBA 06/2010 - 04/2010
1	SilverIBA 06/2022
1	Essential Amino AcidsIBA 06/2022
1	Phosphates (Orthophosphate)IBA 03/2022
1	Sirtuin 3IBA 02/2022
1	ImmunosorbentsIBA 02/2022
1	AntagomirsIBA 02/2022
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	InflammasomesIBA 02/2022
1	NS 1619IBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022
1	3- ((5- chloro- 2- hydroxyphenyl)methyl)- 5- (4- (trifluoromethyl)phenyl)- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2022
1	CollagenIBA 01/2022
1	Iron-Binding ProteinsIBA 01/2022
1	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2022
1	VimentinIBA 01/2022
1	low density lipoprotein triglycerideIBA 08/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2021

Therapy/Procedure

7	Therapeutics 01/2022 - 05/2013
2	Length of Stay 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 04/2017 - 09/2007
1	Operative Time 01/2022